2 Healthcare Stocks That Could Soar Over the Next 5 Years

2026-03-26 17:50:00 ET

While the stock market is facing significant volatility right now, there is a decent chance it will still perform fairly well over the next five years. That's what we have come to expect from equities, given their track record over the past decades. So, it might still be a good idea to invest in stocks right now, but not just any will do. Let's consider two healthcare companies that have the potential to perform better than broader equities through the next half a decade: Moderna (NASDAQ: MRNA) and Abivax (NASDAQ: ABVX) .

Image source: Getty Images.

Moderna's shares could soar as it advances its mRNA platform. Compared to older vaccines, those of the mRNA variety have advantages, including being much faster to produce and sometimes eliciting stronger, more targeted immune responses. Moderna was able to develop and market a coronavirus vaccine quickly for a reason. Now, it is going after other targets. Moderna developed a flu vaccine that is being considered for approval in the U.S. Although there are already options on the market, their efficacy generally falls between about 40% and 60% -- Moderna is looking to improve that.

Continue reading